Inhibitors of ADAMTS13: a Potential Factor in the Cause of Thrombotic Microangiopathy in a Renal Allograft Recipient
Overview
Authors
Affiliations
Background: Thrombotic microangiopathy (TMA) is a well-known complication after renal allograft transplantation. In most cases, calcineurin inhibitor is believed to play a role in the development of this disorder. Recent studies have shown that a deficiency in the activity of the von Willebrand factor-cleaving metalloprotease ADAMTS13 causes thrombotic thrombocytopenic purpura. A similar mechanism occurring in patients who develop TMA after renal transplantation has not been described.
Methods: Analysis of plasma samples from a patient who developed TMA after receiving a cadaveric renal allograft revealed undetectable ADAMTS13 activity and the presence of its inhibitors.
Results: Discontinuation of cyclosporine and daily plasma exchange increased the ADAMTS13 activity, which was followed by resolution of the microangiopathic hemolysis and improvement of the graft function. At 3-month follow-up, the ADAMTS13 activity remained in the normal range and no inhibitors were detected.
Conclusions: This is the first case to demonstrate a correlation between the presence of ADAMTS13 inhibitors and transplant-associated TMA. Autoimmune inhibitors of ADAMTS13 should be considered in patients with transplant-associated thrombotic microangiopathy. The role of calcineurin inhibitor in the formation of autoantibodies to ADAMTS13 remains to be explored.
Halkidis K, Meng C, Pillai V, Shay M, Liu S, Zheng X Res Pract Thromb Haemost. 2024; 8(7):102603.
PMID: 39624585 PMC: 11609530. DOI: 10.1016/j.rpth.2024.102603.
Hsiung C, Chen H, Wang S, Huang C Transpl Int. 2024; 37:12168.
PMID: 38323071 PMC: 10844394. DOI: 10.3389/ti.2024.12168.
Pepin M, Saca E, Kwon S, May J Clin Case Rep. 2021; 9(10):e04850.
PMID: 34667601 PMC: 8507438. DOI: 10.1002/ccr3.4850.
Avila A, Gavela E, Sancho A Front Med (Lausanne). 2021; 8:642864.
PMID: 33898482 PMC: 8063690. DOI: 10.3389/fmed.2021.642864.
Thrombotic microangiopathy after renal transplantation: Current insights in and recurrent disease.
Abbas F, Kossi M, Kim J, Sharma A, Halawa A World J Transplant. 2018; 8(5):122-141.
PMID: 30211021 PMC: 6134269. DOI: 10.5500/wjt.v8.i5.122.